Author: Sklar CA, Antal Z, Chemaitilly W, Cohen LE, Follin C, Meacham LR, Murad MH
Year: 2018
AGREE II score: Available
Developer organization: Endocrine Society
Type of cancer: Not disease site specific
Patient population: Adult, Pediatric
Location: International
This is a clinical practice guideline for survivors of childhood cancer. The guideline provides recommendations for the endocrine treatment of hypothalamic-pituitary and growth disorders in these patients. Specific conditions discussed include impaired linear growth, growth hormone deficiency, central precocious puberty, hypogonadotropic hypogonadism, and thyroid-stimulating hormone deficiency.
AGREE II - Quality of Reporting Assessment:
Scope and purpose: 91.7%
Applicability: 10.4%
Stakeholder involvement: 75%
Editorial independence: 91.7%
Rigour: 65.6%
Clarity presentation: 86.1%
